Average symptom trajectories following incident radiographic knee osteoarthritis: data from the Osteoarthritis Initiative by Whittle, R et al.
SHORT REPORT
Average symptom trajectories following
incident radiographic knee
osteoarthritis: data from the
Osteoarthritis Initiative
Rebecca Whittle, Kelvin P Jordan, Elaine Thomas, George Peat
To cite: Whittle R,
Jordan KP, Thomas E, et al.
Average symptom trajectories
following incident
radiographic knee
osteoarthritis: data from the
Osteoarthritis Initiative. RMD
Open 2016;2:e000281.
doi:10.1136/rmdopen-2016-
000281
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
rmdopen-2016-000281).
Received 17 March 2016
Revised 12 May 2016
Accepted 29 May 2016
Arthritis Research UK
Primary Care Centre,
Research Institute for
Primary Care & Health
Sciences, Keele University,
Staffordshire, UK
Correspondence to
Rebecca Whittle;
r.l.whittle@keele.ac.uk
ABSTRACT
Introduction: Previous research has identified the
existence of a prodromal phase of symptom worsening
beginning on average 2–3 years prior to the first
appearance of radiographic knee osteoarthritis (OA).
The current study extends these observations to
investigate the trajectory of self-reported pain, stiffness,
function and other symptoms following the incidence
of radiographic OA.
Methods: Data were from the incidence cohort of the
Osteoarthritis Initiative public use data sets. Cases were
defined as knees without symptoms at enrolment,
which developed incident radiographic OA (Kellgren
and Lawrence grade ≥2) at any of the first 4 annual
follow-up visits. Symptoms investigated were knee-
specific Western Ontario & McMaster Universities
Osteoarthritis Index and Knee injury and Osteoarthritis
Outcome Score subscale scores and individual items,
available up to 3 years before and 5 years after the
incidence of radiographic OA. Trajectories of having at
least one of the symptoms from a subscale, and for
each individual symptom over time, were fitted using
multilevel logistic regression models.
Results: The probability of symptoms following the
initial prodromal phase generally stabilised, whereas
the probability of moderate, severe or extreme
symptoms was consistently low. Two exceptions were
pain frequency, which increased greatly in the lead up
to incidence, then decreased slightly, and audible joint
sounds, which had a much higher overall probability,
and after increasing prior to incident radiographic OA,
stabilised then started to increase again at 5 years.
Conclusions: Following an increase in the risk of
symptoms during the prodromal phase, this risk does
not continue to increase in the period up to 5 years
after the incidence of radiographic OA.
INTRODUCTION
Observations by Felson et al1 support the
hypothesis that disease progression in knee
osteoarthritis (OA) follows a pattern of
inertia in which knees showing recent inci-
dent change in X-ray are at higher risk of
further X-ray progression. Given well-
documented structure–pain discordance in
OA, it is less clear whether patients’ reported
experience of pain and function follow a
similar pattern. This is important since the
experience of symptoms and functional limi-
tation drive help-seeking and should there-
fore feature in preventive strategies based on
early diagnosis.
In a previous analysis of repeated-measures
data in a cohort of adults at high risk of knee
OA, we found that symptoms began to appear
or worsen, on average, 2–3 years prior to the
ﬁrst appearance of incident radiographic
knee OA (ROA: deﬁned as Kellgren and
Lawrence (KL) grade ≥2)—a ‘prodromal
phase’.2 Here, we extend these observations
forward in time to establish if this increase in
symptoms during the prodromal phase is fol-
lowed by further symptom worsening.
Key messages
What is already known about this subject?
▸ In adults at high risk of knee osteoarthritis (OA)
symptoms begin to appear or worsen, on
average, 2-3 years prior to the first appearance
of incident radiographic knee OA.
What does this study add?
▸ We extended these findings forward in time and
demonstrated that following an increase in the
risk of symptoms prior to the incidence of radio-
graphic knee OA, this risk does not continue to
increase in the period up to 5 years after
incidence.
How might this impact on clinical practice?
▸ Patients undergoing an underlying transition in
OA disease state may experience episodic
symptom worsening but this does not inevitably
presage further symptom decline in the short-
to-medium term.
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METHODS
Data set
We used data from the Osteoarthritis Initiative (OAI)3
(available for public access at http://www.oai.ucsf.edu/).
Between 2004 and 2006, 3284 participants aged 45–
79 years were enrolled in the ‘incidence subcohort’ of
the OAI if they were at high risk of developing symptom-
atic ROA. Individuals with rheumatoid arthritis or other
inﬂammatory arthritis were excluded. Measures recorded
from self-complete questionnaires, personal interviews,
physical examinations and plain radiography were col-
lected on enrolment and were repeated at annual clinic
visits. All participants signed informed consent, and the
study was approved by the institutional review board.
Selection of participants
Cases were deﬁned as knees without symptoms (deﬁned
as knee pain, aching or stiffness: more than half the days
of a month, past 12 months) on enrolment into the
OAI, which had developed incident ROA (KL grade
≥2), deﬁned as the new onset of combined deﬁnite
osteophyte and joint space narrowing in the tibiofemoral
joint4 (ascertained from ﬁxed-ﬂexion knee radiographs),
at any of the ﬁrst four annual follow-up visits. Cases were
assigned a common baseline time point, t0, correspond-
ing to when incident ROA was ﬁrst identiﬁed. Knees that
were surgically replaced were censored at the last visit
before the knee replacement was recorded.
Outcome measures
Outcomes, measured annually up to 3 years before and
5 years after incident ROA, were the Western Ontario &
McMaster Universities Osteoarthritis Index (WOMAC5),
Pain, Physical Function and Stiffness subscales and Knee
injury and Osteoarthritis Outcome Score (KOOS6), Pain
and Other Symptoms subscales (dichotomised into at least
one item in the subscale rated ‘moderate’, ‘severe’ or
‘extreme’ vs all items in the subscale rated ‘none’ or
‘mild’) and 34 individual items from the WOMAC and
KOOS scales (dichotomised: ‘none’/‘mild’ vs ‘moderate’/
‘severe’/‘extreme’; see ref. 2). For the current analyses, we
used the knee-speciﬁc subscale scores and individual items
as previously studied in the prodromal phase.2
Statistical analysis
Trajectories of the probabilities of symptoms over time
were estimated with random intercept multilevel logistic
regression models,7 adjusting for age and gender, treat-
ing each knee as an individual case while accounting for
correlation between knees within people. Complete case
analysis was performed.
RESULTS
One hundred and sixty-nine cases of incident ROA were
recorded in 161 participants during the ﬁrst 4 years of
follow-up of the OAI cohort (68, 31, 47 and 23 knees at
years 1, 2, 3 and 4, respectively). At cohort entry: mean
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age 65.2 years (SD 9.2); 69% female; mean BMI 29.2 kg/
m2 (SD 4.6); 42.6% previous knee injury; 20.7% previous
knee surgery; 72% with KL=1. Approximately 25% of
knees had at least one symptom (individual item) present
at t0 on each WOMAC subscales, reducing to ∼15% by t0
+1 for Pain and Stiffness and 23% for Physical
Functioning with little further change by t0+5 (table 1).
The probability of having at least one symptom in
each of the subscales generally stabilised or lessened fol-
lowing the initial prodromal phase with mostly non-
signiﬁcant associations of time after t0, for example,
ORs for WOMAC Stiffness peak at t0 (OR at t0+1: 0.55
(95% CI 0.31 to 0.97)), suggesting that stiffness symp-
toms reduce in the year after incidence. Similar results
were found across the individual items (data not shown).
Two items to note were pain frequency (weekly or more;
measured in KOOS), which increased greatly in the lead
up to incident ROA and then decreased slightly, and
audible joint sounds ( sometimes or more; measured in
KOOS), which had a much higher overall probability,
and after increasing prior to incident radiographic OA,
stabilised then increased again at 5 years (ﬁgure 1). On
removing knees which progressed to a higher KL grade
up to 3 years after t0 (n=22, 13%), there was very little
change to the trajectories (data not shown).
DISCUSSION
Following an increase in the risk of symptoms during
the prodromal phase, this risk does not continue to
increase in the period up to 5 years after the incidence
of ROA. Instead, on most measures, it appears to
stabilise or lessen, but not to prior levels. Reasons for
the observed stabilisation or reduction of symptoms after
incident ROA include the possible effect of treatment
or, as alluded to by Hutton,8 a process of adaptation at
the level of the joint and/or individual. An important
caveat is that this may apply only in the absence of
further disease progression since relatively few knees in
this analysis progressed to KL grade ≥3 during the
period of observation after incident ROA.
While undergoing the transition to incident ROA, a
high proportion of knees were not at any time reported as
having ‘moderate’ or worse symptoms: 50% of knees did
not have ‘moderate’, ‘severe’ or ‘extreme’ symptoms on
any individual items in the WOMAC Stiffness subscale;
36% on WOMAC Physical Function subscale; 43% on
WOMAC Pain; 20% on KOOS Pain and 25% on KOOS
Other Symptoms. Only 3–10% did not have even ‘mild’
symptoms on at least one item. The transition to incident
ROA is therefore not entirely ‘silent’, but symptom
changes may be subtle and may not trigger help-seeking.
Rather than immediate clinical application, our ﬁndings
serve to advance our understanding of the temporal rela-
tionship between symptom change and disease progres-
sion, raising the possibility of episodic symptom worsening
in response to an underlying transition in disease state.
We have studied prodromal2 and postdromal symptom
trajectories anchored around the transition to incident
tibiofemoral ROA (KL grade ≥2). Extending this
approach to earlier, preradiographic index events and
states based on MRI and identifying preventable prox-
imal triggers (eg, recent injury) is warranted.
Figure 1 Example of trajectories for individual items: data from the Osteoarthritis Initiative, USA, 2004–2012 (from top left to
bottom right: probability of scoring moderate, severe or extreme (pain walking and difficulty descending stairs), probability of
experiencing pain weekly, daily or always and probability of feeling grinding, hearing clicking or any other type of noise
sometimes, often or always. Time 0 represents the time of incident radiographic knee osteoarthritis).
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